These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15106088)

  • 1. Summary and conclusions: measles elimination meeting, 16-17 March 2000.
    Katz SL; Hinman AR
    J Infect Dis; 2004 May; 189 Suppl 1():S43-7. PubMed ID: 15106088
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of measles elimination strategies in the United States.
    Hinman AR; Orenstein WA; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S17-22. PubMed ID: 15106084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward interruption of endemic measles transmission in Tunisia.
    Garbouj M; Slim A; Ghorbal MB; Khamassi S; Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S172-6. PubMed ID: 12721910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
    J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles elimination in the Russian Federation, 2003-2009.
    Onishchenko G; Ezhlova E; Gerasimova A; Tsvirkun O; Shulga S; Lipskaya G; Mamayeva T; Aleshkin V; Tikhonova N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S366-72. PubMed ID: 21666186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.
    Martin R; Wassilak S; Emiroglu N; Uzicanin A; Deshesvoi S; Jankovic D; Goel A; Khetsuriani N
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S325-34. PubMed ID: 21666181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles surveillance.
    CDR (Lond Engl Wkly); 1991 Dec; 1(50):221. PubMed ID: 1669898
    [No Abstract]   [Full Text] [Related]  

  • 9. Interruption of measles transmission in Brazil, 2000-2001.
    Prevots DR; Parise MS; Segatto TC; Siqueira MM; dos Santos ED; Ganter B; Perreira MC; Domingues CA; Lanzieri T; Da Silva JB
    J Infect Dis; 2003 May; 187 Suppl 1():S111-20. PubMed ID: 12721901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Philippines 2004 measles campaign: a success story towards elimination.
    Sobel H; Ducusin J; De Quiroz M; Cabotaje M; Olivé JM
    Trop Doct; 2009 Jan; 39(1):36-8. PubMed ID: 19211423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles mortality reduction and pre-elimination in the African region, 2001-2009.
    Masresha BG; Fall A; Eshetu M; Sosler S; Alleman M; Goodson JL; Katsande R; Nshimirimana D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S198-204. PubMed ID: 21666162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
    Garry SF
    Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward measles elimination--Japan, 1999-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated measles control in the Western Pacific region.
    McFarland JW; Mansoor OD; Yang B
    J Infect Dis; 2003 May; 187 Suppl 1():S246-51. PubMed ID: 12721921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles elimination in the United States.
    Orenstein WA; Papania MJ; Wharton ME
    J Infect Dis; 2004 May; 189 Suppl 1():S1-3. PubMed ID: 15106120
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.
    Hutchins SS; Baughman AL; Orr M; Haley C; Hadler S
    J Infect Dis; 2004 May; 189 Suppl 1():S108-15. PubMed ID: 15106099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards elimination of measles in the Americas. WHO expanded programme on immunization.
    Can Commun Dis Rep; 1998 Jun; 24(11):94-6. PubMed ID: 9629836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.